Pomegranate may benefit dialysis patientsStudy links the fruit’s juice with reduced inflammation and hospitalizations due to infections and heart troubles Avoid statins in patients with intracerebral hemorrhageUncertain whether statins advisable in patients at high risk for ICH. New drugs get a rise out of HDL Phase II trials look promising, but larger outcome studies needed Cholesterol deposits on eyelids give insight into heart disease The eyes have it—a clue to heart disease, that is. Stillbirth and repeat miscarriages carry heart attack risk Thelin (sitaxsentan): PAH drug withdrawn worldwide Pfizer Canada is voluntarily withdrawing Thelin from the market worldwide due to concerns about hepatotoxicity. Lowering urate cuts cardiovascular deaths Hyperuricemia deserves more aggressive treatment, researcher says Teens: Cut the salt for future health Model predicts 3 g decrease in daily intake prevents thousands of cardiovascular events Huge trial backs cardiac resynchronization therapy Combined ICD-CRT device cuts mortality and heart failure hospitalizations Wireless feedback aids BP control Patient involvement is key to the success of telemonitoring, say Canadian researchers First Previous 72 73 74 75 76 Next Last
